IMTXA33αS shows a highly specific and effective cytotoxicity against colon cancer target cells (SW1222 or LIM1215) overexpressing the GPA33 antigen, with IC50 (protein concentration inhibiting 50% of protein synthesis) values of 30 and 70 nM, respectively. Here, GPA33 is linked to colonic neoplasm.